cells of peripherally circulating blood which indicate
a functional relation among endogen antioxidants and
the occurrence of systemic oxidative stress (Briganti
& Picardo, 2002). Arican et al in 2008 and Agrawal
et al in 2014 also found the mean of catalase level in
erythrocytes on vitiligo patients were significantly
lower than normal controls (Arican et al., 2008;
Agrawal et al., 2004).
Superoxide dismutase is the first line enzymatic
antioxidant transforming a reactive superoxide anion
O
2
•-
to become hydrogen peroxide H
2
O
2
that
subsequently will turned into H
2
O and O
2
with the
activity of catalase that act as the second line
enzymatic antioxidant (Le Quere et al., 2014, Sravani
et al., 2009).
The accumulation of H
2
O
2
can cause
inactivation of catalase enzyme that will result in
more H
2
O
2
excess and damage to the cells (Hazneci
et al., 2004; Dammak et al., 2009). This disturbed
antioxidant activity showed by increase of SOD and
decrease of catalase had been proved both in the
lesional and non-lesional skin of vitiligo patients and
also in melanocytes in vitro (Schallreuter et al., 1999;
Maresca et al., 1997).Accumulation of H
2
O
2
will
undergo a Fenton and Haber-Weiss reaction to
produce a very reactive hydroxyl radical (OH
•
) that
very toxic to melanocytes and considered as the cause
of melanocyte deaths so that the increase of SOD and
decrease of catalase are related to the progressivity
and severity of vitiligo (Laddha et al., 2014).
5 CONCLUSIONS
There were significant positive correlation between
plasma SOD level and severity of vitiligo based on
VASI score and significant negative correlation
between plasma catalase level and severity of vitiligo
based on VASI score.
ACKNOWLEDGEMENTS
This study is funded by Study and Development Unit
of Medical Faculty Udayana University on 2017.
REFERENCES
Agrawal, D., Shajil, E.M., Marfatia, Y.S. and Begum, R.,
2004. Study on the antioxidant status of vitiligo patients
of different age groups in Baroda. Pigment cell
research, 17(3), pp.289-294.
Alikhan, A., Felsten, L.M., Daly, M. and Petronic-Rosic,
V., 2011. Vitiligo: a comprehensive overview: part I.
Introduction, epidemiology, quality of life, diagnosis,
differential diagnosis, associations, histopathology,
etiology, and work-up. Journal of the American
Academy of Dermatology, 65(3), pp.473-491.
Arican, O. and Kurutas, E.B., 2008. Oxidative stress in the
blood of patients with active localized vitiligo. Acta
Dermatovenerologica Alpina Panonica Et
Adriatica, 17(1), p.12.
Briganti, S. and Picardo, M., 2003. Antioxidant activity,
lipid peroxidation and skin diseases. What's
new. Journal of the European Academy of
Dermatology and Venereology, 17(6), pp.663-669.
Dammak, I., Boudaya, S., Ben Abdallah, F., Turki, H.,
Attia, H. and Hentati, B., 2009. Antioxidant enzymes
and lipid peroxidation at the tissue level in patients with
stable and active vitiligo. International journal of
dermatology, 48(5), pp.476-480.
Denat, L., Kadekaro, A.L., Marrot, L., Leachman, S.A. and
Abdel-Malek, Z.A., 2014. Melanocytes as instigators
and victims of oxidative stress. Journal of Investigative
Dermatology, 134(6), pp.1-7.
Hazneci, E., Karabulut, A.B., Öztürk, Ç., Batçioğlu, K.,
Doğan, G., Karaca, Ş. and Eşrefoğlu, M., 2005. A
comparative study of superoxide dismutase, catalase,
and glutathione peroxidase activities and nitrate levels
in vitiligo patients. International journal of
dermatology, 44(8), pp.636-640.
Laddha, N.C., Dwivedi, M., Mansuri, M.S., Singh, M.,
Gani, A.R., Yeola, A.P., Panchal, V.N., Khan, F., Dave,
D.J., Patel, A. and Madhavan, S.E., 2014. Role of
oxidative stress and autoimmunity in onset and
progression of vitiligo. Experimental
dermatology, 23(5), pp.352-353.
Le Quere S., Lacan D., Lemaire B., Carillon J., Schmitt K.,
2014. The Role of Superoxide Dismutase in Skin
Disorders: A Review. Nutrafoods, 13, pp.13-27.
Maresca, V., Roccella, M., Roccella, F., Camera, E., Del
Porto, G., Passi, S., Grammatico, P. and Picardo, M.,
1997. Increased sensitivity to peroxidative agents as a
possible pathogenic factor of melanocyte damage in
vitiligo. Journal of investigative dermatology, 109(3),
pp.310-313.
Parsad, D., Dogra, S. and Kanwar, A.J., 2003. Quality of
life in patients with vitiligo. Health and quality of life
outcomes, 1(1), p.58.
Schallreuter, Karin U., Jeremy Moore, John M. Wood,
Wayne D. Beazley, David C. Gaze, Desmond J. Tobin,
Harriet S. Marshall, Angela Panske, Eberhard Panzig,
and Nigel A. Hibberts. "In vivo and in vitro evidence
for hydrogen peroxide (H2O2) accumulation in the
epidermis of patients with vitiligo and its successful
removal by a UVB-activated pseudocatalase."
In Journal of Investigative Dermatology Symposium
Proceedings, vol. 4, no. 1, pp. 91-96. Elsevier, 1999.
Sravani, P.V., Babu, N.K., Gopal, K.V.T., Rao, G.R.R.,
Rao, A.R., Moorthy, B. and Rao, T.R., 2009.
Determination of oxidative stress in vitiligo by
measuring superoxide dismutase and catalase levels in
vitiliginous and non-vitiliginous skin. Indian Journal of
Dermatology, Venereology, and Leprology, 75(3),
p.268.